Isabelle Dehaene1, Kristien Roelens2, Koenraad Smets3, Johan Decruyenaere4. 1. Obstetrics and Gynaecology, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium. isabelle.dehaene@ugent.be. 2. Obstetrics and Gynaecology, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium. 3. Neonatal Intensive Care Unit, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium. 4. Intensive Care Unit, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Abstract
PURPOSE: To critically analyse the literature on the antenatal corticosteroids (ACS)-to-birth interval from a causal point of view and to present a solution to the problem of bias caused by post hoc analysis. METHODS: Due to the post hoc nature of the ACS-to-birth interval, a randomised controlled trial (RCT) of ACS versus placebo is not able to examine the importance of the interval. When an RCT is not feasible, for whatsoever reason, a target trial can be set up and an attempt can be made to answer the causal question of interest using observational data. An attempt was made to set up a target trial which could enable to examine the causal effect of the ACS-to-birth interval on neonatal outcomes. An analysis of current literature on the ACS-to-birth interval was done. RESULTS: The majority of studies aimed to examine the causal effect of the interval, but their study design only permitted to find associations between the interval and neonatal outcomes. Barriers for setting up a target trial are highlighted. CONCLUSION: Evidence on the superiority of any ACS-to-birth interval is lacking and the question can only be addressed causally and become clinically relevant if baseline randomisation to ACS-to-birth intervals is made possible.
PURPOSE: To critically analyse the literature on the antenatal corticosteroids (ACS)-to-birth interval from a causal point of view and to present a solution to the problem of bias caused by post hoc analysis. METHODS: Due to the post hoc nature of the ACS-to-birth interval, a randomised controlled trial (RCT) of ACS versus placebo is not able to examine the importance of the interval. When an RCT is not feasible, for whatsoever reason, a target trial can be set up and an attempt can be made to answer the causal question of interest using observational data. An attempt was made to set up a target trial which could enable to examine the causal effect of the ACS-to-birth interval on neonatal outcomes. An analysis of current literature on the ACS-to-birth interval was done. RESULTS: The majority of studies aimed to examine the causal effect of the interval, but their study design only permitted to find associations between the interval and neonatal outcomes. Barriers for setting up a target trial are highlighted. CONCLUSION: Evidence on the superiority of any ACS-to-birth interval is lacking and the question can only be addressed causally and become clinically relevant if baseline randomisation to ACS-to-birth intervals is made possible.
Authors: Merel M C Bruijn; Jolande Y Vis; Femke F Wilms; Martijn A Oudijk; Anneke Kwee; Martina M Porath; Guid Oei; Hubertina C J Scheepers; Marc E A Spaanderman; Kitty W M Bloemenkamp; Monique C Haak; Antoinette C Bolte; Frank P H A Vandenbussche; Mallory D Woiski; Caroline J Bax; Jérôme M J Cornette; Johannes J Duvekot; Bas W A Nij Bijvank; Jim van Eyck; Maureen T M Franssen; Krystyna M Sollie; Joris A M van der Post; Patrick M M Bossuyt; Brent C Opmeer; M Kok; Ben W J Mol; Gert-Jan van Baaren Journal: Eur J Obstet Gynecol Reprod Biol Date: 2016-09-20 Impact factor: 2.435
Authors: Caroline A Crowther; Philippa F Middleton; Merryn Voysey; Lisa Askie; Sasha Zhang; Tanya K Martlow; Fariba Aghajafari; Elizabeth V Asztalos; Peter Brocklehurst; Sourabh Dutta; Thomas J Garite; Debra A Guinn; Mikko Hallman; Pollyanna Hardy; Men-Jean Lee; Kimberley Maurel; Premasish Mazumder; Cindy McEvoy; Kellie E Murphy; Outi M Peltoniemi; Elizabeth A Thom; Ronald J Wapner; Lex W Doyle Journal: PLoS Med Date: 2019-04-12 Impact factor: 11.069
Authors: Nir Melamed; Elizabeth Asztalos; Kellie Murphy; Arthur Zaltz; Donald Redelmeier; Baiju R Shah; Jon Barrett Journal: BMJ Open Date: 2019-09-30 Impact factor: 2.692
Authors: Caroline A Crowther; Fariba Aghajafari; Lisa M Askie; Elizabeth V Asztalos; Peter Brocklehurst; Tanya K Bubner; Lex W Doyle; Sourabh Dutta; Thomas J Garite; Debra A Guinn; Mikko Hallman; Mary E Hannah; Pollyanna Hardy; Kimberly Maurel; Premasish Mazumder; Cindy McEvoy; Philippa F Middleton; Kellie E Murphy; Outi M Peltoniemi; Dawn Peters; Lisa Sullivan; Elizabeth A Thom; Merryn Voysey; Ronald J Wapner; Lisa Yelland; Sasha Zhang Journal: Syst Rev Date: 2012-02-12